Related Experiment Video
Updated: Oct 3, 2025

Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
Published on: July 20, 2022
Hypertrophic Cardiomyopathy and Atrial Fibrillation: A Review
Vishnu Palyam1, Ahmad T Azam2, Oladipo Odeyinka3
1Internal Medicine, Jagadguru Jayadeva Murugarajendra Medical College, Davanagere, IND.
Insights
Atrial fibrillation (AF) in hypertrophic cardiomyopathy (HCM) stems from diastolic dysfunction and left atrial changes. Management involves lifestyle, anticoagulation, and rhythm control to reduce mortality risks.
Area of Science:
- Cardiology
- Genetics
Background:
- Hypertrophic cardiomyopathy (HCM) is a primary inherited cardiac condition.
- Atrial fibrillation (AF) is a common complication in HCM patients.
- AF in HCM is linked to diastolic dysfunction and left atrial remodeling.
Purpose of the Study:
- To examine the development and clinical impact of AF in HCM.
- To highlight management strategies for AF in HCM.
- To review mortality associated with AF in HCM.
Main Methods:
- Literature review of studies on AF in HCM.
- Analysis of clinical symptomatology and impact.
- Examination of management approaches including lifestyle, anticoagulation, and rhythm control.
Main Results:
- Advanced diastolic dysfunction and left atrial dilatation are key drivers of AF in HCM.
- AF contributes to symptomatic decline, increased thromboembolism, and mortality.
- Effective management combines lifestyle changes, anticoagulation, and rhythm control strategies.
Conclusions:
- AF significantly impacts HCM prognosis, increasing morbidity and mortality.
- Comprehensive management is crucial for improving outcomes in HCM patients with AF.
- Further research into optimal AF management in HCM is warranted.
Abstract:
Hypertrophic cardiomyopathy (HCM) is an inherited cardiological condition that exhibits various clinical symptoms. The leading cause of atrial fibrillation (AF) in patients with HCM is advanced diastolic dysfunction and left atrial dilatation and remodeling. In addition to the gradual symptomatic and functional decline caused by AF, there is an increased risk of thromboembolic disease and mortality, especially if there is a rapid ventricular rate or obstruction of the left ventricular outflow tract. The mainstay of management of AF in HCM is a combination of non-pharmacological lifestyle and risk factor modification, long-term anticoagulation, and rhythm control with anti-arrhythmic medications, septal ablation, and radiofrequency catheter ablation. This article has examined the development of AF in HCM, its clinical symptomatology, and its impact, highlighting its management and the mortality associated with AF in HCM.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
Rheumatic Heart Disease I: Introduction

